Citations

Clear

97 citation(s) found for "Ghanem, R".

Marginal Ulcer and Dumping Syndrome in Patients after Duodenal Switch: A Multi-Centered Study
Salame, Marita , Teixeira, André , Lind, Romulo , Ungson, Gilberto , Ghanem, Muhammad , Mosleh, Kamal Abi , Jawad, Muhammad A. , Kendrick, Michael L. , Ghanem, Omar M. , Abi Mosleh, Kamal , Dayyeh, Barham K. Abu

Mayo Clinic

Journal of Clinical Medicine | August 28, 2023 | Volume: 12 | Issue: 17 | Pages: 5600

10.3390/jcm12175600 | PMID 37685666 Get It

Background: The current design of biliopancreatic diversion with duodenal switch (BPD/DS) and single anastomosis duodenal–ileal bypass with sleeve (SADI-S) emphasizes the importance of the pylorus’ preservation to reduce the incidence of marginal ulcer (MU) and dumping. However, no institutional studies have yet reported data on their prevalence. We aimed to assess the incidence of MU and dumping after duodenal switch (DS) and identify the associative factors. Methods: A multi-center review of patients who underwent BPD/DS or SADI-S between 2008 and 2022. Baseline demographics, symptoms, and management of both complications were collected. Fisher’s exact test was used for categorical variables and the independent t-test for continuous variables. Results: A total of 919 patients were included (74.6% female; age 42.5 years; BMI 54.6 kg/m2) with mean follow-up of 31.5 months. Eight patients (0.9%) developed MU and seven (0.8%) had dumping. Patients who developed MU were more likely to be using non-steroidal anti-inflammatory drugs (NSAID) (p = 0.006) and have a longer operation time (p = 0.047). Primary versus revisional surgery, and BDP/DS versus SADI-S were not associated with MU or dumping. Conclusions: The incidences of MU and dumping after DS were low. NSAID use and a longer operation time were associated with an increased risk of MU, whereas dumping was attributed to poor dietary habits.
P-028 Impact of the covid-19 pandemic on the intracranial aneurysm treatment and associated outcomes: a propensity score matching study
Ghaith, Ahmed , Nieves, Antonio Bon, Kashyap, Sonu , Bydon, Mohamad , Ghaith, A, Ghanem, M, Greco, E, Ríos-Zermeño, Jorge , Tawk, Rabih G.

Mayo Clinic

SNIS 20th annual meeting oral poster abstracts | July 30, 2023 | Volume: No volume available | Issue: No issue available | Pages: A74-A74

10.1136/jnis-2023-snis.100 Get It

Marginal Ulcers after Roux-en-Y Gastric Bypass: Etiology, Diagnosis, and Management
Salame, Marita , Belluzzi, Amanda, Al-Kordi, Mohammad, Jawhar, Noura , Storm, Andrew C. , Dayyeh, Barham K. Abu , Ghanem, Omar M.

Mayo Clinic

Journal of Clinical Medicine | June 28, 2023 | Volume: 12 | Issue: 13 | Pages: 4336

10.3390/jcm12134336 | PMID 37445371 Get It

Marginal ulcer (MU) is a potential complication following Roux-en-Y gastric bypass (RYGB), with a mean prevalence of 4.6%. Early identification and prompt intervention are crucial to mitigating further complications. The pathophysiology of MU is complex and involves multiple factors, including smoking, Helicobacter pylori infection, non-steroidal anti-inflammatory drug (NSAID) use, and larger pouch size. Patients with MU may experience acute or chronic abdominal pain. Rarely, they may present with a complication from the ulceration, such as bleeding, perforation, or strictures. Following diagnosis by endoscopy, management of MU typically involves modification of risk factors and medical therapy focused on proton pump inhibitors. In case of complicated ulcers, surgical intervention is often required for the repair of the perforation or resection of the stricture. For recurrent or recalcitrant ulcers, endoscopic coverage of the ulcer bed, resection of the anastomosis, and abdominal or thoracoscopic truncal vagotomy may be considered. This review aims at providing an overview of the etiology, diagnosis, and management of MU after RYGB.
Turnkey algorithmic approach for the evaluation of gastroesophageal reflux disease after bariatric surgery
Ghanem, Omar M. , Ghazi, Rabih , Razzak, Farah Abdul, Bazerbachi, Fateh , Khaitan, Leena , Kothari, Shanu N. , Abdul Razzak, Farah, Bazerbachi, F , Razzak, Farah Abdul, Ravi, Karthik , Dayyeh, Barham K. Abu

Mayo Clinic

Gastroenterology Report | June 10, 2023 | Volume: 11 | Issue: No issue available | Pages: No page available

10.1093/gastro/goad028 | PMID 37304555 Get It

Abstract Bariatric surgeries are often complicated by de-novo gastroesophageal reflux disease (GERD) or worsening of pre-existing GERD. The growing rates of obesity and bariatric surgeries worldwide are paralleled by an increase in the number of patients requiring post-surgical GERD evaluation. However, there is currently no standardized approach for the assessment of GERD in these patients. In this review, we delineate the relationship between GERD and the most common bariatric surgeries: sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB), with a focus on pathophysiology, objective assessment, and underlying anatomical and motility disturbances. We suggest a stepwise algorithm to help diagnose GERD after SG and RYGB, determine the underlying cause, and guide the management and treatment.
Using machine learning to predict 30-day readmission and reoperation following resection of supratentorial high-grade gliomas: an ACS NSQIP study involving 9418 patients
Ghanem, Marc , Zamanian, Cameron , Bon‐Nieves, Antonio , Bhandarkar, Archis R. , Bydon, Mohamad , Quiñones‐Hinojosa, Alfredo , Bon-Nieves, Antonio A, Bhandarkar, Archis, Nathani, Karim, Bon-Nieves, Antonio A , Ghaith, Abdul Karim , Nathani, Karim Rizwan

Mayo Clinic

Neurosurgical Focus | June 1, 2023 | Volume: 54 | Issue: 6 | Pages: E12

10.3171/2023.3.focus22652 | PMID 37552633 Get It

OBJECTIVE High-grade gliomas (HGGs) are among the rarest yet most aggressive tumor types in neurosurgical practice. In the current literature, few studies have assessed the drivers of early outcomes following resection of these tumors and investigated their association with quality of care. The authors aimed to identify the clinical predictors for 30-day readmission and reoperation following HGG surgery using the American College of Surgeons (ACS) National Surgical Quality Improvement Project (NSQIP) database and sought to create web-based applications predicting each outcome. METHODS Using the ACS NSQIP database, the authors conducted a retrospective, multicenter cohort analysis of patients who underwent resection of supratentorial HGGs between January 1, 2016, and December 31, 2020. Demographics and comorbidities were extracted. The primary outcomes were 30-day unplanned readmission and reoperation. A stratified 80:20 split of the available data was carried out. Supervised machine learning algorithms were trained to predict 30-day outcomes. RESULTS A total of 9418 patients were included in our cohort. The observed rate of unplanned readmission within 30 days of surgery was 13.0% (n = 1221). In terms of predictors, weight, chronic steroid use, preoperative blood urea nitrogen level, and white blood cell count were associated with a higher risk of readmission. The observed rate of unplanned reoperation within 30 days of surgery was 5.2% (n = 489). In terms of predictors, increased weight, longer operative time, and more days between hospital admission and operation were associated with an increased risk of early reoperation. The random forest algorithm showed the highest predictive performance for early readmission (area under the curve [AUC] = 0.967), while the XGBoost algorithm showed the highest predictive performance for early reoperation (AUC = 0.985). Web-based tools for both outcomes were deployed ( https://glioma-readmission.herokuapp.com/ and https://glioma-reoperation.herokuapp.com/ ). CONCLUSIONS In this study, the authors provide the first nationwide analysis for short-term outcomes in patients undergoing resection of supratentorial HGGs. Multiple patient, hospital, and admission factors were associated with readmission and reoperation, confirmed by machine learning predicting patients’ prognosis, leading to better planning preoperatively and subsequently improved personalized patient care.
Impact of Early Gastrojejunal Stenosis on Weight Loss in Patients Undergoing Roux-en-Y Gastric Bypass
Shariq, Omair A. , Portela, Ray , Bews, Katherine A. , Kellogg, Todd A., Dayyeh, Barham Abu, Kendrick, Michael L. , Ghanem, Omar M. , Mundi, Manpreet S. , Kellogg, Todd A., Habermann, Elizabeth B.

Mayo Clinic

Surgical Laparoscopy, Endoscopy & Percutaneous Techniques | March 27, 2023 | Volume: 33 | Issue: 2 | Pages: 202-206

10.1097/sle.0000000000001165 | PMID 36971521 Get It

Background: Gastrojejunal (GJ) anastomotic stenosis is a well-described complication after Roux-en-Y gastric bypass (RYGB); however, its impact on weight loss outcomes is not well elucidated. Methods: We performed a retrospective cohort study of adult patients who underwent RYGB at our institution between 2008 and 2020. Propensity score matching was used to match 30 patients who developed GJ stenosis within the first 30 days post-RYGB with 120 control patients who did not develop this outcome. Short and long-term complications and mean percentage of total body weight loss (TWL) were recorded at 3 months, 6 months, 1 year, 2 years, 3 to 5 years, and 5 to 10 years postoperatively. Hierarchical linear regression modeling was used to analyze the association between early GJ stenosis and the mean percentage of TWL. Results: Patients who developed early GJ stenosis had a 13.6% increase in the mean percentage of TWL when compared with controls in the hierarchical linear model [P < 0.001 (95% CI: 5.7; 21.5)]. These patients were also more likely to present to an intravenous infusion center (70% vs 4%; P < 0.01), require readmission within 30 days (16.7% vs 2.5%; P < 0.01), and/or develop an internal hernia (23.3% vs 5.0%) postoperatively. Conclusions: Patients who develop early GJ stenosis after RYGB have a greater degree of long-term weight loss compared with patients who do not develop this complication. Although our findings support the key contribution that restrictive mechanisms play in maintaining weight loss after RYGB, GJ stenosis remains a complication associated with significant morbidity.
Utility of Diagnostic Tests Before Reimplantation in Patients Undergoing 2-Stage Revision Total Joint Arthroplasty
Khan, Irfan A. , Boyd, Brandon , Chen, Antonia F. , Cortés-Penfield, Nicolás , Myers, Thomas G. , Brown, Timothy S. , Suh, Gina A. , McGwin, Gerald , Ghanem, Elie , Fillingham, Yale A. , Boyd, Brandon O , Ghanem, Elie S , Suh, Gina A , Chen, Antonia F

Mayo Clinic

JBJS Reviews | March 22, 2023 | Volume: 11 | Issue: 3 | Pages: No page available

10.2106/jbjs.rvw.22.00201 | PMID 36947634 Get It

Introduction: Periprosthetic joint infection (PJI) is a devastating complication after total joint arthroplasty (TJA), with treatment failure occurring in 12% to 28% after 2-stage revision. It is vital to identify diagnostic tools indicative of persistent infection or treatment failure after 2-stage revision for PJI. Methods: The Cochrane Library, PubMed (MEDLINE), and EMBASE were searched for randomized controlled trials and comparative observational studies published before October 3, 2021, which evaluated the utility of serum/plasma biomarkers (erythrocyte sedimentation rate [ESR], C-reactive protein [CRP], interleukin-6 [IL-6], fibrinogen, D-dimer), synovial biomarkers (white blood cell [WBC] count, neutrophil percentage [PMN %], alpha-defensin [AD], leukocyte esterase [LE]), tissue frozen section, tissue culture, synovial fluid culture, or sonicated spacer fluid culture indicative of persistent infection before the second stage of 2-stage revision for PJI or treatment failure after 2-stage revision for PJI. Results: A total of 47 studies including 6,605 diagnostic tests among 3,781 2-stage revisions for PJI were analyzed. Among those cases, 723 (19.1%) experienced persistent infection or treatment failure. Synovial LE (sensitivity 0.25 [0.10-0.47], specificity 0.99 [0.93-1.00], positive likelihood ratio 14.0 [1.45-135.58]) and serum IL-6 (sensitivity 0.52 [0.33-0.70], specificity 0.92 [0.85-0.96], positive likelihood ratio 7.90 [0.86-72.61]) had the highest diagnostic accuracy. However, no biomarker was associated with a clinically useful negative likelihood ratio. In subgroup analysis, synovial PMN %, synovial fluid culture, serum ESR, and serum CRP had limited utility for detecting persistent infection before reimplantation (positive likelihood ratios ranging 2.33-3.74; negative likelihood ratios ranging 0.31-0.9) and no utility for predicting failure after the second stage of 2-stage revision. Conclusions: Synovial WBC count, synovial PMN %, synovial fluid culture, serum ESR, and serum CRP have modest sensitivity and specificity for predicting persistent infection during the second stage of 2-stage revision, suggesting some combination of these diagnostic tests might be useful before reimplantation. No biomarker or culture accurately predicted treatment failure after reimplantation. Level of Evidence: Level III . See Instructions for Authors for a complete description of levels of evidence.
Author response to: Comment on: Risk of non-hormonal cancer after bariatric surgery: meta-analysis of retrospective observational studies
Nakanishi, Hayato , Portela, Ray , Clapp, Benjamin , Ghanem, Omar M.

Mayo Clinic

British Journal of Surgery | March 14, 2023 | Volume: 110 | Issue: 5 | Pages: 619-620

10.1093/bjs/znad069 | PMID 36917639 Get It

Author response to: Comment on: Risk of non-hormonal cancer after bariatric surgery: meta-analysis of retrospective observational studies
Ghanem, Omar M. , Portela, Ray , Clapp, Benjamin

Mayo Clinic

British Journal of Surgery | January 7, 2023 | Volume: 110 | Issue: 3 | Pages: 388-388

10.1093/bjs/znac454 | PMID 36609560 Get It

Risk of non-hormonal cancer after bariatric surgery: meta-analysis of retrospective observational studies
Clapp, Benjamin , Portela, Ray , Sharma, Ishna , Nakanishi, Hayato , Marrero, Katie , Dayyeh, Barham Abu, Kendrick, Michael, Ghanem, Omar M. , Abu Dayyeh, Barham, Schauer, Philip R , Hálfdánarson, Þorvarður R.

Mayo Clinic

British Journal of Surgery | October 4, 2022 | Volume: 110 | Issue: 1 | Pages: 24-33

10.1093/bjs/znac343 | PMID 36259310 Get It

Abstract Background Obesity is associated with an increased incidence of at least 13 types of cancer. Although bariatric surgery has been associated with a reduced risk of hormonal cancers, data for non-hormonal cancers are scarce. The aim of this study was to evaluate the effect of bariatric surgery on the incidence of non-hormonal cancers. Methods Cochrane, Embase, PubMed, Scopus, and Web of Science were searched for articles between 1984 and 2018, following the PRISMA system. Meta-analysis was conducted using a random-effect model with subgroup analysis by procedure and cancer type. Results From 2526 studies screened, 15 were included. There were a total of 18 583 477 patients, 947 787 in the bariatric group and 17 635 690 in the control group. In comparison to the non-surgical group, the bariatric group had a lower incidence of cancer (OR .65 (95 per cent c.i. 0.53 to 0.80); P &lt; 0.002). In the subgroup analysis, Roux-en-Y gastric bypass and sleeve gastrectomy were associated with decreased risk of developing cancer, while no difference was observed with adjustable gastric banding. When evaluated by cancer type, liver (OR 0.417 (95 per cent c.i. 0.323 to 0.538)), colorectal (OR 0.64 (95 per cent c.i. 0.49 to 0.84)), kidney and urinary tract cancer (OR 0.77 (95 per cent c.i. 0.72 to 0.83)), oesophageal (OR 0.60 (95 per cent c.i. 0.43 to 0.85)), and lung cancer (OR 0.796 (95 per cent c.i. 0.45 to 0.80)) also presented a lower cancer incidence in the bariatric group. Conclusion Bariatric surgery is related to an almost 50 per cent reduction in the risk of non-hormonal cancers.